Bank of America’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-42
| Closed | -$39 | – | 8595 |
|
|
2024
Q1 | $39 | Hold |
42
| – | – | ﹤0.01% | 7459 |
|
|
2023
Q4 | $86 | Buy |
42
+33
| +367% | +$85 | ﹤0.01% | 7428 |
|
|
2023
Q3 | $33 | Sell |
9
-4
| -31% | -$17 | ﹤0.01% | 7541 |
|
|
2023
Q2 | $62 | Sell |
13
-15
| -54% | -$73 | ﹤0.01% | 7452 |
|
|
2023
Q1 | $128 | Sell |
28
-43
| -61% | -$242 | ﹤0.01% | 7470 |
|
|
2022
Q4 | $322 | Buy |
71
+54
| +318% | +$348 | ﹤0.01% | 7482 |
|
|
2022
Q3 | $0 | Buy |
17
+3
| +21% | +$105 | ﹤0.01% | 8502 |
|
|
2022
Q2 | $1K | Sell |
14
-14
| -50% | -$1.04K | ﹤0.01% | 7941 |
|
|
2022
Q1 | $4K | Sell |
28
-170
| -86% | -$24.8K | ﹤0.01% | 7959 |
|
|
2021
Q4 | $34K | Buy |
198
+181
| +1,065% | +$67.5K | ﹤0.01% | 7366 |
|
|
2021
Q3 | $8K | Buy |
17
+2
| +13% | +$927 | ﹤0.01% | 7645 |
|
|
2021
Q2 | $7K | Sell |
15
-57
| -79% | -$30.6K | ﹤0.01% | 7385 |
|
|
2021
Q1 | $36K | Buy |
72
+57
| +380% | +$29.4K | ﹤0.01% | 6737 |
|
|
2020
Q4 | $7K | Hold |
15
| – | – | ﹤0.01% | 6792 |
|
|
2020
Q3 | $4K | Hold |
15
| – | – | ﹤0.01% | 6636 |
|
|
2020
Q2 | $3K | Hold |
15
| – | – | ﹤0.01% | 6636 |
|
|
2020
Q1 | $2K | Hold |
15
| – | – | ﹤0.01% | 6671 |
|
|
2019
Q4 | $3K | Sell |
15
-2
| -12% | -$258 | ﹤0.01% | 6858 |
|
|
2019
Q3 | $3K | Sell |
17
-1,759
| -99% | -$234K | ﹤0.01% | 6957 |
|
|
2019
Q2 | $206K | Buy |
1,776
+1,765
| +16,045% | +$280K | ﹤0.01% | 5619 |
|
|
2019
Q1 | $2K | Sell |
11
-130
| -92% | -$22.3K | ﹤0.01% | 6929 |
|
|
2018
Q4 | $17K | Buy |
141
+120
| +571% | +$18.4K | ﹤0.01% | 6528 |
|
|
2018
Q3 | $3K | Sell |
21
-7
| -25% | -$2.93K | ﹤0.01% | 6984 |
|
|
2018
Q2 | $19K | Sell |
28
-65
| -70% | -$48.6K | ﹤0.01% | 6528 |
|
|
2018
Q1 | $95K | Buy |
93
+65
| +232% | +$54.4K | ﹤0.01% | 5762 |
|
|
2017
Q4 | $34K | Sell |
28
-22
| -44% | -$10.3K | ﹤0.01% | 6230 |
|
|
2017
Q3 | $9K | Hold |
50
| – | – | ﹤0.01% | 6594 |
|
|
2017
Q2 | $8K | Sell |
50
-29
| -37% | -$5.87K | ﹤0.01% | 6499 |
|
|
2017
Q1 | $19K | Buy |
79
+7
| +10% | +$1.88K | ﹤0.01% | 6336 |
|
|
2016
Q4 | $20K | Buy |
72
+15
| +26% | +$3.57K | ﹤0.01% | 6343 |
|
|
2016
Q3 | $12K | Buy |
57
+53
| +1,325% | +$14.9K | ﹤0.01% | 6331 |
|
|
2016
Q2 | $1K | Sell |
4
-273
| -99% | -$298K | ﹤0.01% | 7033 |
|
|
2016
Q1 | $187K | Buy |
+277
| New | +$187K | ﹤0.01% | 5167 |
|
|
2015
Q3 | – | Sell |
-24
| Closed | -$17K | – | 7492 |
|
|
2015
Q2 | $17K | Buy |
24
+4
| +20% | +$4.26K | ﹤0.01% | 6401 |
|
|
2015
Q1 | $46K | Buy |
20
+9
| +82% | +$15.3K | ﹤0.01% | 5701 |
|
|
2014
Q4 | $11K | Sell |
11
-77
| -88% | -$82.3K | ﹤0.01% | 7032 |
|
|
2014
Q3 | $94K | Buy |
88
+83
| +1,660% | +$140K | ﹤0.01% | 6060 |
|
|
2014
Q2 | $13K | Buy |
+5
| New | +$10.2K | ﹤0.01% | 7373 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 8190 |
|
|
2013
Q4 | – | Sell |
-1
| Closed | -$2.36K | – | 8222 |
|
|
2013
Q3 | $3K | Sell |
1
-7
| -88% | -$13.5K | ﹤0.01% | 7558 |
|
|
2013
Q2 | $13K | Buy |
+8
| New | +$12.7K | ﹤0.01% | 7104 |
|
Other funds holding AMPE
Bank of America's AMPE Position: Q2 2024 in Review
Bank of America sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 42 shares — an estimated $39 sold.
Bank of America first reported a position in AMPE in Q2 2013 and held it in 40 quarters. The position peaked at $206K in Q2 2019. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.
- Bank of America reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
- Bank of America sold 42 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $39.
- Bank of America first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 40 quarters.
- Bank of America's Ampio Pharmaceuticals Inc. position peaked at $206K in Q2 2019.
- 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.
Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.